PharmaSGP Holding SE is strengthening its Management Board team with Maria-Johanna Schaecher (55) as Chief Business Development Officer (CBDO). As of September 16, 2020, she will play a key role in driving forward the implementation of the growth strategy together with CEO Natalie Weigand and CFO Michael Rudolf. The company is thus increasing its management capacities to be able to take even more advantage of the growth opportunities that arise both nationally and internationally. Maria-Johanna Schaecher has around 30 years of experience in the management of international companies. At the beginning of her career, she worked for the strategy consultancy BCG for over eight years, last as a Principal. She subsequently held a number of top management positions in the healthcare, biotech, pharmaceutical, food and agricultural industries as Managing Director, Board member and Advisory Board member. As General Manager she was amongst others responsible for the medical devices business of Johnson & Johnson in Germany. As a member of the European Board of Applied Biosystems, Schaecher played a key role in the company's international expansion. Most recently, she successfully served as CEO of a medium-sized company with sales of over EUR 700 million. She has extensive management experience, particularly in the development of new business areas and the successful implementation of internationalization strategies. Within the scope of her management positions and various Advisory Board mandates, she also accompanied the entire process of numerous successful acquisitions and sales of companies up to the management of the entire integration implementation.